Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Antisense and antigene inhibition of gene expression by cell-permeable oligonucleotide-oligospermine conjugates.

Gagnon KT, Watts JK, Pendergraff HM, Montaillier C, Thai D, Potier P, Corey DR.

J Am Chem Soc. 2011 Jun 8;133(22):8404-7. doi: 10.1021/ja200312y.

2.

Oligonucleotide-oligospermine conjugates (zip nucleic acids): a convenient means of finely tuning hybridization temperatures.

Noir R, Kotera M, Pons B, Remy JS, Behr JP.

J Am Chem Soc. 2008 Oct 8;130(40):13500-5. doi: 10.1021/ja804727a.

PMID:
18781743
3.

Structure Tuning of Cationic Oligospermine-siRNA Conjugates for Carrier-Free Gene Silencing.

Nothisen M, Bagilet J, Behr JP, Remy JS, Kotera M.

Mol Pharm. 2016 Aug 1;13(8):2718-28. doi: 10.1021/acs.molpharmaceut.6b00309.

PMID:
27398779
4.

Inhibiting gene expression with locked nucleic acids (LNAs) that target chromosomal DNA.

Beane RL, Ram R, Gabillet S, Arar K, Monia BP, Corey DR.

Biochemistry. 2007 Jun 26;46(25):7572-80.

5.

Cationic siRNAs provide carrier-free gene silencing in animal cells.

Nothisen M, Kotera M, Voirin E, Remy JS, Behr JP.

J Am Chem Soc. 2009 Dec 16;131(49):17730-1. doi: 10.1021/ja908017e.

PMID:
19928854
6.

Recognition of chromosomal DNA by PNAs.

Kaihatsu K, Janowski BA, Corey DR.

Chem Biol. 2004 Jun;11(6):749-58. Review.

7.
9.
10.
12.

Oligonucleotides and oligonucleotide conjugates: a new approach for cancer treatment.

Da Ros T, Spalluto G, Prato M, Saison-Behmoaras T, Boutorine A, Cacciari B.

Curr Med Chem. 2005;12(1):71-88. Review.

PMID:
15638731
13.

Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.

Tsuda N, Matsumoto A, Ito A, Uneda T, Tanabe A, Obika S, Imanishi T.

Nucleic Acids Symp Ser (Oxf). 2005;(49):335-6.

PMID:
17150770
14.

Sequence-specific control of gene expression by antigene and clamp oligonucleotides.

Hélène C, Giovannangeli C, Guieysse-Peugeot AL, Praseuth D.

Ciba Found Symp. 1997;209:94-102; discussion 102-6. Review.

PMID:
9383571
15.

Cell penetrating peptide conjugates of steric block oligonucleotides.

Lebleu B, Moulton HM, Abes R, Ivanova GD, Abes S, Stein DA, Iversen PL, Arzumanov AA, Gait MJ.

Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):517-29. Review.

PMID:
18037527
16.

Versatile synthesis of oligodeoxyribonucleotide-oligospermine conjugates.

Voirin E, Behr JP, Kotera M.

Nat Protoc. 2007;2(6):1360-7.

PMID:
17545974
17.

Zorro locked nucleic acid induces sequence-specific gene silencing.

Ge R, Heinonen JE, Svahn MG, Mohamed AJ, Lundin KE, Smith CI.

FASEB J. 2007 Jun;21(8):1902-14.

PMID:
17314142
18.

Targeted delivery of antisense oligonucleotides by molecular conjugates.

Bunnell BA, Askari FK, Wilson JM.

Somat Cell Mol Genet. 1992 Nov;18(6):559-69.

19.

Inhibitory properties of double-helix-forming circular oligonucleotides.

Azhayeva E, Azhayev A, Auriola S, Tengvall U, Urtti A, Lönnberg.

Nucleic Acids Res. 1997 Dec 15;25(24):4954-61.

20.

The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides.

Hélène C.

Anticancer Drug Des. 1991 Dec;6(6):569-84. Review.

PMID:
1772570
Items per page

Supplemental Content

Support Center